2017 IEEE International Conference on Healthcare Informatics
Copyright and Reprint Permissions: Abstracting is permitted with credit to the source. Libraries may photocopy beyond the limits of US copyright law, for private use of patrons, those articles in this volume that carry a code at the bottom of the first page, provided that the per-copy fee indicated in the code is paid through the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923.
Other copying, reprint, or republication requests should be addressed to: IEEE Copyrights Manager, IEEE Service Center, 445 Hoes Lane, P.O. Box 133, Piscataway, NJ 08855-1331.
The papers in this book comprise the proceedings of the meeting mentioned on the cover and title page. They reflect the authors’ opinions and, in the interests of timely dissemination, are published as presented and without change. Their inclusion in this publication does not necessarily constitute endorsement by the editors, the IEEE Computer Society, or the Institute of Electrical and Electronics Engineers, Inc.
We propose a new mathematical growth model of primary tumor and primary metastases which may help to improve predicting accuracy of breast cancer process using an original mathematical model referred to CoM-IV and corresponding software. The CoM-IV model and predictive software: a) detect different growth periods of primary tumor and primary metastases; b) make forecast of patient survival; c) have higher average prediction accuracy than the other tools; d) can improve forecasts on survival of BC and facilitate optimisation of diagnostic tests. The CoM-IV enables us, for the first time, to predict the whole natural history of primary tumor and primary metastases growth on each stage (pT1, pT2, pT3, pT4) considering only on primary tumor sizes. Summarising: CoM-IV a) describes correctly primary tumor and primary distant metastases growth of IV (T1-4N0-3M1) stage with (N1-3) or without regional metastases in lymph nodes (N0); b) facilitates the understanding of the appearance period and manifestation of primary metastases.